European Journal of Chemistry

Rapid chiral separation and impurity determination of ropivacaine and bupivacaine by Densitometry-HPTLC, using mucopolysaccharide as chiral mobile phase additive



Main Article Content

Nahla Nour El-Din Salama

Abstract

Enantio separation of the local anesthetic drugs; ropivacaine (Rop), bupivacaine (Bup) and potential organic impurities (2,6-Dimethylaniline, 2,6-DMA) were accomplished on HPTLC using mucopolysaccharide selector (Chondroitin) as chiral mobile phase additive (CMPA). The enantioseparation was achieved in acetonitrile:water:methanol (16:3:1, v:v:v) containing 0.25% chondroitin as chiral mobile phase additive. The influence of separation conditions, including type and concentration of chiral selector, organic modifiers and temperatures on enantioseparation were evaluated. The enantioselective HPTLC method was validated to control the enantiomeric purity of the (S)-enantiomers (S-Rop and S-Bup); the active ingredients contained in drug products. In these conditions, linearity over the concentration range, 1.0-10.0 µg/spot for each (R)-enantiomer and 1.0-8.0 µg/spot for 2,6-DMA main organic impurity were obtained. The detection limits are less than 0.6 µg/spot of chiral and organic impurities. The intra and inter-day assay precision was less than 3.0% (RSD%).


icon graph This Abstract was viewed 1724 times | icon graph Article PDF downloaded 853 times

How to Cite
(1)
Salama, N. N. E.-D. Rapid Chiral Separation and Impurity Determination of Ropivacaine and Bupivacaine by Densitometry-HPTLC, Using Mucopolysaccharide As Chiral Mobile Phase Additive. Eur. J. Chem. 2014, 5, 214-218.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Wainer, I. W.; Editor, Drug Stereochemistry: Analytical Methods and Pharmacology, 2nd Ed., Marcel Dekker, New York, 1993.

[2]. Albright, G. A. Anesthesiology 1979, 51, 285-287.
http://dx.doi.org/10.1097/00000542-197910000-00001

[3]. Burlacu, C. L.; Buggy, D. J. Ther. Clin. Risk. Manag. 2008, 4, 381-392.

[4]. McClure, J. H. Br. J. Anaesth. 1996, 76, 300-307.
http://dx.doi.org/10.1093/bja/76.2.300

[5]. Valenzuela, C. V.; Snyders, D. J.; Bennett, P. B.; Tamargo, J.; Hondeghem, L. M. Circulation 1995, 92, 3014-3024.
http://dx.doi.org/10.1161/01.CIR.92.10.3014

[6]. Tsuchiya, H.; Mizogami, M. Local Reg. Anesth. 2008, 1, 1-9.

[7]. Amini, A.; Javerfalk, E.; Bastami, S.; Westerlund, D. Electrophoresis 1999, 20, 204-211.
http://dx.doi.org/10.1002/(SICI)1522-2683(19990101)20:1<204::AID-ELPS204>3.0.CO;2-I

[8]. Javerfalk, E. M.; Amini, A.; Westerlund, D.; Andren, P. E. J. Mass Spectrom. 1998, 33, 183-186.
http://dx.doi.org/10.1002/(SICI)1096-9888(199802)33:2<183::AID-JMS622>3.0.CO;2-V

[9]. Tang, W.; Muderawan, I. W.; Siu-Choon, N. G.; Chan, H. S. O. Anal. Chim. Acta 2006, 555, 63-67.
http://dx.doi.org/10.1016/j.aca.2005.08.064

[10]. Amini, A.; Wiersma, B.; Westerlund, D.; Paulsen-Sorman, U. Eur. J. Pharm. Sci. 1999, 9, 17-24.
http://dx.doi.org/10.1016/S0928-0987(99)00035-4

[11]. Fanali, S. J. Chromatogr. A 2000, 875, 89-122.
http://dx.doi.org/10.1016/S0021-9673(99)01309-6

[12]. Gubitz, G.; Schmid, M. G. Electrophoresis 2000, 21, 4112-4135.
http://dx.doi.org/10.1002/1522-2683(200012)21:18<4112::AID-ELPS4112>3.0.CO;2-T

[13]. Nishi, H. J. Chromatogr. A 1997, 792, 327-347.
http://dx.doi.org/10.1016/S0021-9673(97)00794-2

[14]. Nystrom, A.; Strandberg, A.; Aspegren, A.; Behr, S.; Karlsson, A. Chromatographia 1999, 50, 208-219.
http://dx.doi.org/10.1007/BF02490653

[15]. Tanaka, Y.; Terabe, S. Chromatographia 1999, 49, 489-495.
http://dx.doi.org/10.1007/BF02467747

[16]. Schneiderman, E.; Stalcup, A. M. J. Chromatogr. B 2000, 745, 83-102.
http://dx.doi.org/10.1016/S0378-4347(00)00057-8

[17]. Arvidsson, T.; Bruce, H. F.; Halldin, M. M. Chirality 1995, 7, 272-277.
http://dx.doi.org/10.1002/chir.530070414

[18]. Salama, N. N. J. Planar Chromatogr. Mod. TLC. 2008, 21, 441-446.
http://dx.doi.org/10.1556/JPC.21.2008.6.9

[19]. Taha, E. A. Curr. Pharm. Chem. 2007, 3, 273-277.

[20]. ICH Q2A. Validation of analytical methods definitions and terminology, in IFPMA (ed.), International Conference on Harmonization, Geneva 1994.

[21]. ICH Q2B. Validation of analytical procedure methodology, in IFPMA (ed.), International Conference on Harmonization, Geneva 1996.

[22]. Aboul-Enein, H. Y.; El-Awady, M. I.; Heard, C. H. J. Pharm. Biomed. Anal. 2003, 32, 1055-1059.
http://dx.doi.org/10.1016/S0731-7085(03)00208-5

Supporting Agencies

Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).